Unfortunately, due to the small number of BRCA2 gPV carriers with a DNA test before cancer diagnosis, we were unable to draw meaningful conclusions from the prospective analyses among BRCA2 gPV carriers and matched sporadic patients. The gene discussed is BRCA2; the disease is cancer.